Anzeige
Mehr »
Login
Donnerstag, 30.01.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Gold-Rally Richtung 3.000 $: Der brasilianische Gold-Play, das Sie kennen sollten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
381 Leser
Artikel bewerten:
(2)

Turacoz Healthcare Solutions Private Limited: Turacoz Group Showcases Expertise in Medical Communication at BioEurope Spring 2024 in Barcelona

Finanznachrichten News

UTRECHT, Netherlands and NEW DELHI, April 3, 2024 /PRNewswire/ -- Turacoz Group, a leading medical communication company, recently participated in BioEurope's 18th edition held in Barcelona from March 18th to 20th, 2024. The event, known for connecting the global biopharma community to foster life science partnerships, provides an excellent overview of life sciences industry trend.

Turacoz Group exploring innovative medical communication solutions with industry experts at BioEurope Spring 2024 in Barcelona.

BioEurope Spring serves as a pivotal platform for industry players to gain insights into emerging trends, network with innovative start-ups, and forge partnerships with global pharma companies. Turacoz Group utilized this opportunity to connect with key stakeholders across the biopharma spectrum, including innovators in drug development, pharma experts, investors, and service providers.

During the three-day event, Turacoz Group's representatives Ashish Pandey along with Turacoz founder Dr. Namrata Singh, engaged intensively with industry leaders to highlight Turacoz's unique ability to create Clear, Cohesive, Complete, Concise, and Concrete scientific communication in a target-specific language and format. This expertise is crucial for biopharma companies facing challenges in effectively communicating complex scientific data, especially in areas of rare diseases and strict regulatory compliance.

"BioEurope Spring provided us with a remarkable opportunity to interact with industry pioneers and showcase how Turacoz can revolutionize medical communication. Our experience and utilization of emerging technologies especially generative AI uniquely position us to support life sciences companies throughout their product life cycle, ensuring accurate and impactful communication with diverse stakeholders," said Dr. Namrata Singh, founder of Turacoz Group.

Turacoz Group's participation at BioEurope Spring underscores its commitment to advancing medical communication through innovative strategies. By empowering biopharma companies with tailored communication solutions, Turacoz aims to enhance and drive innovation in the life sciences industry.

About Turacoz Group:

Turacoz Group is a leading global medical communications agency. We partner with the life sciences industry to communicate science and medicine in an innovative manner across the entire product life cycle from development to commercialization.

Our team combines scientific expertise, creativity, and industry knowledge to deliver solutions that are highly effective for our clients.

With a strategic presence in five key locations across Europe, North America, and Asia, Turacoz Group is uniquely positioned to offer its deep domain expertise to biopharmaceutical, emerging biotech, medical device companies and research institutes globally.

Photo - https://mma.prnewswire.com/media/2377890/Turacoz_Group_BioEurope.jpg
Logo - https://mma.prnewswire.com/media/2378422/4629330/Turacoz_Logo.jpg

Turacoz_Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/turacoz-group-showcases-expertise-in-medical-communication-at-bioeurope-spring-2024-in-barcelona-302107041.html

© 2024 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.